Lars C. Petersen

Bagsvaerd, 2760, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Oxime Coupling of Active Site Inhibited Factor Seven with a Nonvolatile, Water-Soluble Fluorine-18 Labeled Aldehyde.

Oxime Coupling of Active Site Inhibited Factor Seven with a Nonvolatile, Water-Soluble Fluorine-18 Labeled Aldehyde.

Journal: Bioconjugate chemistry

Published: January 25, 2019

Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry.

Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry.

Journal: Bioconjugate chemistry

Published: December 06, 2017

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 16, 2017

Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Journal: Blood

Published: February 06, 2017

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 23, 2015

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 24, 2015

Synthesis and characterization of (18)F-labeled active site inhibited factor VII (ASIS).

Synthesis and characterization of (18)F-labeled active site inhibited factor VII (ASIS).

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: December 03, 2014

Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases.

Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases.

Journal: Journal of drug delivery

Published: August 14, 2014

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Journal: Thrombosis research

Published: February 04, 2014

Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor.

Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor.

Journal: Thrombosis research

Published: October 15, 2013

Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration.

Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 16, 2013

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.

Journal: Blood

Published: May 08, 2012

Showing 1-12 of 18

Last Updated: 09/26/2026